AOB PHARMA Trademark
AOB PHARMA is a USPTO trademark filed by AOBiome LLC. Status: Pending.
Trademark Facts
| Mark | AOB PHARMA |
|---|---|
| Serial Number | 99556326 |
| Status | Pending |
| Filing Date | 2025-12-18 |
| Mark Type | Word |
| Nice Classes | 003 (Cosmetics), 005 (Pharmaceuticals) |
| Owner | AOBiome LLC |
| Attorney of Record | Nathan Timothy Harris |
| Prosecution Events | 10 |
| Latest Event | GNRT on 2026-05-04 |
Goods & Services
Class 003: Creams for cosmetic purposes; cosmetic preparations for body care; cosmetic preparations for skin care; hair care preparations; hair cleaning preparations; hair shampoos; hair conditioners; spray skin care products; cosmetics; tissues impregnated with cosmetic lotions; tissues impregnated with make-up removing preparations; paper towels with skin cleansing fluid; cosmetic toner; deodorants for human beings or for animals; gels for cosmetic purposes; pre-moistened cosmetic wipes, towelettes and tissues; skin fresheners; non-medicated gels for skin care; non-medicated creams for skin care; bath preparations, not for medical purposes; cosmetic preparations for baths; Class 005: Medicated gels, creams, sprays and nasal sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-05-04 | Notice of Non-Final Office Action | NFO |
| 2026-05-04 | Non-Final Action | NFIN |
USPTO Refusals on Record
- disclaimer_required
- indefinite_identification
- standard_loc